Wikidata

(Q53368038)

English

Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26304872
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26304872%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53368038&oldid=1627723512"